José Baselga

发表论文 1383 篇 · 总被引 118646 次 · h-index 143

代表论文

Higher serum activin A predicts adverse outcomes in AI-refractory hormone receptor-positive metastatic breast cancer in the Phase III BOLERO-2 trial (everolimus + exemestane vs exemestane alone) (2026 · SSRN Electronic Journal)
Supplementary Materials and Methods from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling (2023)
Data from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling (2023)
Supplementary Figure S6 from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling (2023)
Supplementary Figure S1 from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling (2023)
Data from Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS–ERK Signaling (2023)